应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
02359 药明康德
休市中 10-23 16:08:09
186.000
+1.800
+0.98%
最高
187.100
最低
176.100
成交量
1,367万
今开
182.000
昨收
184.200
日振幅
5.97%
总市值
5,608亿
流通市值
1,006亿
总股本
30.15亿
成交额
24.86亿
换手率
2.53%
流通股本
5.41亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）
资讯
新帖
简况
10月23日药明康德现9631.12万元大宗交易
证券之星 · 10-23 18:13
10月23日药明康德现9631.12万元大宗交易
ESMO年会开幕，创新药快速拉升，恒生生物科技指数翻红
同花顺 · 10-23 13:56
ESMO年会开幕，创新药快速拉升，恒生生物科技指数翻红
大行评级｜瑞银：上调药明康德目标价至243.9港元，维持为行业首选
格隆汇 · 10-23 11:26
大行评级｜瑞银：上调药明康德目标价至243.9港元，维持为行业首选
异动解读｜药明康德盘中下跌3.2%，业绩披露临近叠加板块走弱
行情直击 · 10-23 09:56
异动解读｜药明康德盘中下跌3.2%，业绩披露临近叠加板块走弱
异动解读｜药明康德盘中下跌3.32%，板块走弱叠加业绩披露临近
行情直击 · 10-22 10:47
异动解读｜药明康德盘中下跌3.32%，板块走弱叠加业绩披露临近
10月21日药明康德现5笔大宗交易 机构净卖出1.62亿元
证券之星 · 10-21 18:03
10月21日药明康德现5笔大宗交易 机构净卖出1.62亿元
Fidelity Canada Investors LLC增持药明康德(02359)77.39万股 每股作价约203.74港元
智通财经 · 10-20
Fidelity Canada Investors LLC增持药明康德(02359)77.39万股 每股作价约203.74港元
10月20日药明康德现1210.81万元大宗交易
证券之星 · 10-20
10月20日药明康德现1210.81万元大宗交易
财报前瞻 | 药明康德本季度营收预计增34.65%，机构观点偏审慎
财报Agent · 10-19
财报前瞻 | 药明康德本季度营收预计增34.65%，机构观点偏审慎
药明康德冲高后突发跳水，全天成交123亿元 发生了什么？
每日经济新闻 · 10-16
药明康德冲高后突发跳水，全天成交123亿元 发生了什么？
港股通创新药止跌向上，520880标的指数摸高4.7%！药明康德尾盘突发跳水，发生了什么？
新浪基金 · 10-16
港股通创新药止跌向上，520880标的指数摸高4.7%！药明康德尾盘突发跳水，发生了什么？
药明康德跌6.6% 中原证券在历史高位给予增持评级
中金财经 · 10-16
药明康德跌6.6% 中原证券在历史高位给予增持评级
CRO概念股持续回落 药明康德尾盘大幅跳水触及跌停
中金财经 · 10-16
CRO概念股持续回落 药明康德尾盘大幅跳水触及跌停
港股生物医药板块午后跳水，药明康德跌超7%
新浪港股 · 10-16
港股生物医药板块午后跳水，药明康德跌超7%
药明康德A股跌超9%
第一财经 · 10-16
药明康德A股跌超9%
创新药概念股续升，康诺亚涨超12%，云顶新耀涨超11%，金斯瑞生物涨近8%
老虎资讯综合 · 10-16
创新药概念股续升，康诺亚涨超12%，云顶新耀涨超11%，金斯瑞生物涨近8%
异动解读｜药明康德盘中上涨3.09%，贝莱德增持H股提升市场情绪
行情直击 · 10-16
异动解读｜药明康德盘中上涨3.09%，贝莱德增持H股提升市场情绪
10月15日药明康德现2笔大宗交易 机构净买入502.13万元
证券之星 · 10-15
10月15日药明康德现2笔大宗交易 机构净买入502.13万元
贝莱德：在药明康德H股的持股比例升至6.44%
格隆汇 · 10-15
贝莱德：在药明康德H股的持股比例升至6.44%
贝莱德在药明康德的H股好仓比例上升1.04%至6.44%
南方财经网 · 10-15
贝莱德在药明康德的H股好仓比例上升1.04%至6.44%
加载更多
公司概况
公司名称：
药明康德
所属市场：
SEHK
上市日期：
--
主营业务：
无锡药明康德新药开发股份有限公司是一家主要从事新药研发和生产服务业务的中国公司。该公司主要通过六个分部开展业务。化学业务分部主要从事提供新药研究、开发与生产服务。测试业务分部主要从事提供药品、医疗器械、体外诊断试剂服务。生物学业务分部主要从事提供药物发现及研究服务。高端治疗合同测试、研发与生产（CTDMO）业务分部主要从事为客户提供医疗产品工艺开发、生产和测试一体化服务。国内新药研发服务部分部主要从事为客户提供一体化新药研发服务。其他业务分部主要从事行政服务、销售原材料和销售废料业务。
发行价格：
--
{"stockData":{"symbol":"02359","market":"HK","secType":"STK","nameCN":"药明康德","latestPrice":186,"timestamp":1792742889004,"preClose":184.2,"halted":0,"volume":13670284,"delay":0,"changeRate":0.0097719869706841,"floatShares":541000000,"shares":3015000000,"eps":7.771314287058676,"marketStatus":"休市中","change":1.8,"latestTime":"10-23 16:08:09","open":182,"high":187.1,"low":176.1,"amount":2485582743,"amplitude":0.059718,"askPrice":186,"askSize":16300,"bidPrice":185.9,"bidSize":28900,"shortable":3,"etf":0,"ttmEps":8.663378868877142,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792978200000},"marketStatusCode":7,"adr":0,"listingDate":1544630400000,"exchange":"SEHK","adjPreClose":184.2,"dividendRate":0.013128,"openAndCloseTimeList":[[1792719000000,1792728000000],[1792731600000,1792742400000]],"volumeRatio":1.869106,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"WXA.HK","astockBrief":{"symbol":"603259","market":"SH","secType":"STK","nameCN":"药明康德","latestPrice":144.72,"timestamp":1792738800000,"preClose":141.31,"halted":0,"volume":55245400,"delay":0,"premium":"+9.32"},"impliedVol":0.6068,"impliedVolPercentile":0.9149},"requestUrl":"/m/hq/s/02359","defaultTab":"news","newsList":[{"id":"2677923806","title":"10月23日药明康德现9631.12万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2677923806","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677923806?lang=zh_cn&edition=full","pubTime":"2026-10-23 18:13","pubTimestamp":1792750384,"startTime":"0","endTime":"0","summary":"证券之星消息，10月23日药明康德发生大宗交易，交易数据如下：大宗交易成交价格144.72元，成交66.55万股，成交金额9631.12万元，买方营业部为国泰海通证券股份有限公司深圳深南大道京基一百证券营业部，卖方营业部为瑞银证券有限责任公司上海花园石桥路证券营业部。近三个月该股共发生31笔大宗交易，合计成交4.34万手。截至2026年10月23日收盘，药明康德报收于144.72元，上涨2.41%，换手率2.23%，成交量55.25万手，成交额77.45亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300033826.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","LU1251922891.USD","LU1046422090.SGD","LU1770034418.SGD","LU0501845795.SGD","LU0708995583.HKD","LU0456842615.SGD","BK1583","LU1997244956.HKD","LU0469268626.HKD","BK1576","IE00BPRC5H50.USD","LU1979443071.USD","LU0572944931.SGD","LU2125910500.SGD","LU0327786744.USD","LU1997245094.SGD","LU1719994722.HKD","LU1655091616.SGD","LU0052750758.USD","IE00B5MMRT66.SGD","603259","LU1808992512.USD","02359","LU1969619763.USD","LU0320764599.SGD","LU0611395673.USD","LU2328871848.SGD","LU2242644610.SGD","LU1934453819.USD","IE00B543WZ88.USD","LU2488822045.USD","LU0072913022.USD","LU2495084118.USD","LU0348766576.USD","LU1255011170.USD","LU1303224171.USD","LU0106959298.USD","BK0216","LU0700851271.USD","LU0348767384.USD","LU1997245177.USD","LU2045819591.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677481109","title":"ESMO年会开幕，创新药快速拉升，恒生生物科技指数翻红","url":"https://stock-news.laohu8.com/highlight/detail?id=2677481109","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677481109?lang=zh_cn&edition=full","pubTime":"2026-10-23 13:56","pubTimestamp":1792734960,"startTime":"0","endTime":"0","summary":"10月23日午后，港股三大指数集体拉升，恒生科技指数一度涨超2%，恒生国企指数、恒生指数跟涨；恒生生物科技指数午后翻红，亚盛医药、翰森制药、科伦博泰生物、先声药业、康方生物等盘中涨幅 ...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261023/c681018111.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261023/c681018111.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["06127","IBBQ","LNGR","03737","02269","MEDX","03759","159992","00570","06160","03613","02273","03347","BK1574","01643","BK1161","09926","01666","06978","02359","06606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677991147","title":"大行评级｜瑞银：上调药明康德目标价至243.9港元，维持为行业首选","url":"https://stock-news.laohu8.com/highlight/detail?id=2677991147","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677991147?lang=zh_cn&edition=full","pubTime":"2026-10-23 11:26","pubTimestamp":1792725996,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["603259","LU1934453819.USD","LU1046422090.SGD","BK1583","LU0501845795.SGD","LU0572944931.SGD","LU0708995583.HKD","LU1255011170.USD","LU0348766576.USD","LU0072913022.USD","BK1576","LU1979443071.USD","IE00B543WZ88.USD","LU0327786744.USD","LU1655091616.SGD","LU1969619763.USD","LU1303224171.USD","IE00B5MMRT66.SGD","LU2328871848.SGD","02359","BK1141","BK0216","LU0700851271.USD","LU1997245094.SGD","LU2488822045.USD","LU0611395673.USD","LU2045819591.USD","LU0052750758.USD","LU0320764599.SGD","LU1997245177.USD","LU1770034418.SGD","LU0106959298.USD","LU1808992512.USD","LU2242644610.SGD","LU2125910500.SGD","LU1997244956.HKD","LU1251922891.USD","LU0456842615.SGD","LU0469268626.HKD","IE00BPRC5H50.USD","LU1719994722.HKD","LU2495084118.USD","LU0348767384.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126766179","title":"异动解读｜药明康德盘中下跌3.2%，业绩披露临近叠加板块走弱","url":"https://stock-news.laohu8.com/highlight/detail?id=1126766179","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1126766179?lang=zh_cn&edition=full","pubTime":"2026-10-23 09:56","pubTimestamp":1792720613,"startTime":"0","endTime":"0","summary":"10月23日，药明康德盘中下跌3.2%，报178.3港元，成交额3.19亿港元。消息面上，公司将于10月26日召开董事会审议前三季度业绩，业绩披露窗口临近。与此同时，生命科学工具和服务板块整体承压，药明生物跌3.23%，药明合联跌2.1%，晶泰控股跌2.9%，拖累公司股价表现。此前公司股价曾在10月中旬出现大幅波动，叠加近期大宗交易中机构出现净卖出，显示短线资金博弈有所加剧。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"药明康德盘中走弱，业绩窗口临近引关注","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150930932","title":"异动解读｜药明康德盘中下跌3.32%，板块走弱叠加业绩披露临近","url":"https://stock-news.laohu8.com/highlight/detail?id=1150930932","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1150930932?lang=zh_cn&edition=full","pubTime":"2026-10-22 10:47","pubTimestamp":1792637257,"startTime":"0","endTime":"0","summary":"10月22日，药明康德盘中下跌3.32%，报189.4港元，成交额4.28亿港元。消息面上，公司将于10月26日召开董事会审议前三季度业绩，业绩披露窗口临近之际，生命科学工具和服务板块整体走弱，拖累股价表现。多空因素交织下，短线资金博弈加剧。生物学业务分部主要从事提供药物发现及研究服务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"药明康德盘中走弱，业绩披露前板块承压","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677077627","title":"10月21日药明康德现5笔大宗交易 机构净卖出1.62亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677077627","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677077627?lang=zh_cn&edition=full","pubTime":"2026-10-21 18:03","pubTimestamp":1792576994,"startTime":"0","endTime":"0","summary":"证券之星消息，10月21日药明康德发生大宗交易，交易数据如下：近三个月该股共发生30笔大宗交易，合计成交3.85万手。该股近期无解禁股上市。截至2026年10月21日收盘，药明康德(603259)报收于147.35元，下跌0.21%，换手率1.14%，成交量28.12万手，成交额41.56亿元。该股最近90天内共有30家机构给出评级，买入评级27家，增持评级3家；过去90天内机构目标均价为197.88。本文数据来源于上海证券交易所大宗交易信息披露，仅供参考不构成投资建议。相关 ETF","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100031124.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1303224171.USD","LU1934453819.USD","LU2328871848.SGD","LU0456842615.SGD","LU1997245177.USD","LU2045819591.USD","LU0320764599.SGD","603259","LU0501845795.SGD","IE00B5MMRT66.SGD","LU1979443071.USD","LU2488822045.USD","LU0327786744.USD","BK1576","LU1997245094.SGD","LU0348767384.USD","LU1255011170.USD","LU1808992512.USD","LU2495084118.USD","LU0052750758.USD","LU0572944931.SGD","02359","LU1251922891.USD","IE00B543WZ88.USD","IE00BPRC5H50.USD","BK1141","LU0611395673.USD","LU1770034418.SGD","BK1583","LU0106959298.USD","LU1997244956.HKD","LU1655091616.SGD","LU1046422090.SGD","LU1969619763.USD","LU0700851271.USD","LU0708995583.HKD","LU0072913022.USD","LU0348766576.USD","LU2125910500.SGD","BK0216","LU2242644610.SGD","LU0469268626.HKD","LU1719994722.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676983356","title":"Fidelity Canada Investors LLC增持药明康德(02359)77.39万股 每股作价约203.74港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2676983356","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676983356?lang=zh_cn&edition=full","pubTime":"2026-10-20 19:29","pubTimestamp":1792495750,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，10月13日，Fidelity Canada Investors LLC增持药明康德(02359)77.39万股，每股作价203.7408港元，总金额约为1.58亿港元。增持后最新持股数目约为2842.04万股，持股比例为5.06%。本交易涉及其他关联方：FIL Limited、Pandanus Associates Inc.、Pandanus Partners L.P.。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1509587.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","BK1576","LU2488822045.USD","LU0700851271.USD","IE00BPRC5H50.USD","LU1046422090.SGD","LU1655091616.SGD","603259","LU0327786744.USD","LU1997244956.HKD","LU2125910500.SGD","LU1997245094.SGD","LU0348766576.USD","LU1969619763.USD","LU1251922891.USD","LU1255011170.USD","LU2495084118.USD","LU2328871848.SGD","LU1979443071.USD","LU1934453819.USD","LU1997245177.USD","IE00B543WZ88.USD","LU2242644610.SGD","LU2045819591.USD","BK0216","LU1808992512.USD","LU0348767384.USD","LU1770034418.SGD","IE00B5MMRT66.SGD","LU1303224171.USD","LU0611395673.USD","EWH","02359","LU0572944931.SGD","LU0469268626.HKD","LU0501845795.SGD","LU0052750758.USD","LU1719994722.HKD","LU0708995583.HKD","LU0072913022.USD","LU0456842615.SGD","LU0106959298.USD","BK1583","LU0320764599.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676692126","title":"10月20日药明康德现1210.81万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2676692126","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676692126?lang=zh_cn&edition=full","pubTime":"2026-10-20 17:27","pubTimestamp":1792488479,"startTime":"0","endTime":"0","summary":"证券之星消息，10月20日药明康德发生大宗交易，交易数据如下：大宗交易成交价格147.66元，成交8.2万股，成交金额1210.81万元，买方营业部为广发证券股份有限公司慈溪浒山路证券营业部，卖方营业部为中国国际金融股份有限公司北京建国门外大街证券营业部。近三个月该股共发生25笔大宗交易，合计成交2.35万手。截至2026年10月20日收盘，药明康德报收于147.66元，上涨0.79%，换手率1.27%，成交量31.45万手，成交额46.27亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102000026572.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2045819591.USD","LU2495084118.USD","LU1719994722.HKD","LU1655091616.SGD","LU1934453819.USD","603259","02359","LU0469268626.HKD","LU1251922891.USD","LU2328871848.SGD","LU1969619763.USD","LU0700851271.USD","LU0106959298.USD","LU2242644610.SGD","BK1576","IE00B5MMRT66.SGD","LU0072913022.USD","LU1808992512.USD","LU0348767384.USD","LU1997244956.HKD","LU0327786744.USD","IE00B543WZ88.USD","IE00BPRC5H50.USD","LU1046422090.SGD","LU1997245094.SGD","LU1770034418.SGD","LU2488822045.USD","LU0456842615.SGD","LU0572944931.SGD","LU0501845795.SGD","LU1979443071.USD","BK1141","BK1583","LU0052750758.USD","LU1255011170.USD","LU1303224171.USD","LU0611395673.USD","LU2125910500.SGD","LU1997245177.USD","BK0216","LU0708995583.HKD","LU0348766576.USD","LU0320764599.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167347536","title":"财报前瞻 | 药明康德本季度营收预计增34.65%，机构观点偏审慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1167347536","media":"财报Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://www.laohunote.com/m/news/1167347536?lang=zh_cn&edition=full","pubTime":"2026-10-19 08:09","pubTimestamp":1792368541,"startTime":"0","endTime":"0","summary":"药明康德将于2026年10月26日发布新一季度财报，市场关注盈利修复节奏与业务结构变化对利润率的影响。市场一致预期显示，本季度药明康德营收预计为153.00亿元，同比增长34.65%；EBIT预计为67.17亿元，同比增长67.66%；调整后每股收益预计为1.81元，同比增长77.71%。上季度公司实现营收164.62亿元，同比增长47.71%；毛利率未披露；归属于母公司股东的净利润为46.52亿元，环比下降34.25%；净利率未披露；调整后每股收益为2.18元，同比增长35.40%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻 | 药明康德本季度营收预计增34.65%，机构观点偏审慎","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2675594252","title":"药明康德冲高后突发跳水，全天成交123亿元 发生了什么？","url":"https://stock-news.laohu8.com/highlight/detail?id=2675594252","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675594252?lang=zh_cn&edition=full","pubTime":"2026-10-16 20:20","pubTimestamp":1792153234,"startTime":"0","endTime":"0","summary":"10月16日午后，药明康德（SH603259）盘中触及跌停。早盘，药明康德股价一度冲高至159.92元，午后转向下挫，盘中最低触及139.05元的跌停价位。全天成交123.40亿元，成交额较前一交易日放量超过一倍；换手率3.38%，振幅约13.5%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610163898568064.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610163898568064.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1303224171.USD","LU1934453819.USD","LU2328871848.SGD","LU0456842615.SGD","LU1997245177.USD","LU2045819591.USD","LU0320764599.SGD","603259","LU0501845795.SGD","IE00B5MMRT66.SGD","LU1979443071.USD","LU2488822045.USD","LU0327786744.USD","BK1576","LU1997245094.SGD","LU0348767384.USD","LU1808992512.USD","LU2495084118.USD","LU0052750758.USD","LU0572944931.SGD","02359","LU1251922891.USD","IE00B543WZ88.USD","IE00BPRC5H50.USD","BK1141","LU0611395673.USD","LU1770034418.SGD","BK1583","LU0106959298.USD","LU1997244956.HKD","LU1046422090.SGD","LU1969619763.USD","LU0700851271.USD","LU0708995583.HKD","LU0072913022.USD","LU0348766576.USD","LU2125910500.SGD","BK0216","LU2242644610.SGD","LU0469268626.HKD","LU1719994722.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675591212","title":"港股通创新药止跌向上，520880标的指数摸高4.7%！药明康德尾盘突发跳水，发生了什么？","url":"https://stock-news.laohu8.com/highlight/detail?id=2675591212","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675591212?lang=zh_cn&edition=full","pubTime":"2026-10-16 19:57","pubTimestamp":1792151820,"startTime":"0","endTime":"0","summary":"10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。早盘创新药全链反攻，港股通创新药ETF华宝、港股通医疗ETF华宝标的指数分别上探4.7%、3.9%，午后受药明系突发跳水影响涨幅收窄，但最终仍各自收涨1.94%、0.19%。捕捉港股医药高弹性机遇，关注两个T+0交易工具：港股通创新药ETF华宝：标的指数100%布局创新药研发类公司，7成仓位押注创新药研发龙头。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-10-16/doc-inivmpqz6915860.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU0052750758.USD","LU1770034418.SGD","BK1583","LU1979443071.USD","LU0572944931.SGD","LU2045819591.USD","520880","LU1997244956.HKD","LU0700851271.USD","LU2495084118.USD","LU0320764599.SGD","LU0327786744.USD","LU0348766576.USD","LU0469268626.HKD","LU2488822045.USD","159992","603259","LU1251922891.USD","LU1997245094.SGD","BK1574","LU1997245177.USD","LU1969619763.USD","IE00BPRC5H50.USD","LU2125910500.SGD","LU0708995583.HKD","02359","LU1934453819.USD","LU1046422090.SGD","06978","MEDX","LU1808992512.USD","LU0456842615.SGD","BK0216","LU0072913022.USD","BK1161","LU0348767384.USD","BK1576","LU0611395673.USD","LNGR","LU0106959298.USD","LU2242644610.SGD","FLHK","LU2328871848.SGD","LU1719994722.HKD","LU0501845795.SGD","BK1141","LU1303224171.USD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675560733","title":"药明康德跌6.6% 中原证券在历史高位给予增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2675560733","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675560733?lang=zh_cn&edition=full","pubTime":"2026-10-16 17:13","pubTimestamp":1792142004,"startTime":"0","endTime":"0","summary":"中国经济网北京10月16日讯 药明康德(603259.SH)今日收报144.30元，跌幅6.60%。\n\n 药明康德股价8月20日盘中创下历史最高点173.60元，并于9月22日盘中创下次高点171.20元。\n\n 中原证券股份有限公司研究员张蔓梓9月18日发布研报《药明康德 (603259)2026年中报点评：下游需求强劲 在手订单量充足》称，首次覆盖给予公司“增持”的投资评级。\n\n (责任编辑：徐自立)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20261016/32399619.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02359","603259","601375"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675613665","title":"CRO概念股持续回落 药明康德尾盘大幅跳水触及跌停","url":"https://stock-news.laohu8.com/highlight/detail?id=2675613665","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675613665?lang=zh_cn&edition=full","pubTime":"2026-10-16 15:16","pubTimestamp":1792134963,"startTime":"0","endTime":"0","summary":"CRO概念股持续回落 药明康德尾盘大幅跳水触及跌停 分时图\n\n 10月16日消息，CRO概念股持续回落，药明康德尾盘大幅跳水触及跌停，成交额106.79亿元，H股跌超7%，药明生物跌超5%。美迪西、康龙化成、昭衍新药跟跌。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202610/16/20261016631760.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202610/16/20261016631760.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/shichangceping/20261016/32399317.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU0700851271.USD","LU1979443071.USD","LU2495084118.USD","LU0501845795.SGD","BK1141","LU0052750758.USD","LU1303224171.USD","603259","LU0572944931.SGD","LU1997244956.HKD","LU2488822045.USD","LU2125910500.SGD","LU0348767384.USD","LU1934453819.USD","LU0106959298.USD","BK1583","IE00BPRC5H50.USD","LU1997245094.SGD","BK0216","LU0348766576.USD","LU2045819591.USD","LU1719994722.HKD","LU0708995583.HKD","LU0469268626.HKD","LU2328871848.SGD","02359","LU1770034418.SGD","LU0327786744.USD","LU0456842615.SGD","LU0072913022.USD","LU1997245177.USD","IE00B5MMRT66.SGD","LU0611395673.USD","BK1576","LU1969619763.USD","LU1251922891.USD","LU1808992512.USD","IE00B543WZ88.USD","LU2242644610.SGD","LU0320764599.SGD","LU1046422090.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675569459","title":"港股生物医药板块午后跳水，药明康德跌超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675569459","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675569459?lang=zh_cn&edition=full","pubTime":"2026-10-16 14:59","pubTimestamp":1792133940,"startTime":"0","endTime":"0","summary":"热点栏目自选股\n数据中心\n行情中心\n资金流向\n模拟交易客户端10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与项飙现场对话！\n名额有限，手慢无。让我们共赴可持续之约！【点击报名】10月16日消息，港股生物医药板块午后跳水，药明康德一度跌超7%，泰格医药跌超4%，药明合联、药明生物跌超1%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/2026-10-16/doc-inivmazq1558839.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4585","LU2495084118.USD","LU1303224171.USD","LU0348767384.USD","LU1046422090.SGD","399441","BK4581","LU0327786744.USD","LU2242644610.SGD","LU0572944931.SGD","LU1808992512.USD","IE00B543WZ88.USD","LU0469268626.HKD","LU0611395673.USD","LU0320764599.SGD","LU0456842615.SGD","BK1141","BK1583","BK4588","KCAI","LU1997245177.USD","XBI","LU0348766576.USD","IE00B5MMRT66.SGD","BK1576","LU1997244956.HKD","LU2125910500.SGD","LU1251922891.USD","LU2328871848.SGD","LU0052750758.USD","LU0501845795.SGD","LU0072913022.USD","LU2488822045.USD","BK0216","161726","IE00BPRC5H50.USD","LU0708995583.HKD","02359","LU1934453819.USD","LU1997245094.SGD","603259","LU1969619763.USD","LU1719994722.HKD","LU0700851271.USD","LU2045819591.USD","LU1770034418.SGD","VXUS","LU0106959298.USD","LU1979443071.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675569301","title":"药明康德A股跌超9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675569301","media":"第一财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675569301?lang=zh_cn&edition=full","pubTime":"2026-10-16 14:47","pubTimestamp":1792133222,"startTime":"0","endTime":"0","summary":"药明康德A股跌超9%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610163898345724.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610163898345724.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02359","07233","82843","IE00B543WZ88.USD","LU1770034418.SGD","LU1934453819.USD","LU1979443071.USD","02843","LU1997245094.SGD","LU2242644610.SGD","82846","399300","LU0572944931.SGD","LU1997244956.HKD","LU0348767384.USD","LU0611395673.USD","LU0320764599.SGD","LU1997245177.USD","03130","82823","LU0072913022.USD","BK1583","LU1808992512.USD","83130","LU0052750758.USD","159982","LU0106959298.USD","03188","82822","BK1576","LU2328871848.SGD","BK1147","LU1046422090.SGD","LU0708995583.HKD","02823","02846","LU0469268626.HKD","LU2488822045.USD","83188","LU2495084118.USD","LU0327786744.USD","LU1303224171.USD","LU0348766576.USD","603259","LU0700851271.USD","LU1719994722.HKD","02822","IE00BPRC5H50.USD","02827","LU2045819591.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109072607","title":"创新药概念股续升，康诺亚涨超12%，云顶新耀涨超11%，金斯瑞生物涨近8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1109072607","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1109072607?lang=zh_cn&edition=full","pubTime":"2026-10-16 09:51","pubTimestamp":1792115499,"startTime":"0","endTime":"0","summary":"港股创新药概念股续升，康诺亚涨超12%，云顶新耀涨超11%，金斯瑞生物涨近8%，百济神州涨超6%，再鼎医药涨近5%，药明合联、药明生物涨超4%，药明康德涨近4%。","market":"hk","thumbnail":"https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952","01548","02268","02269","09688","02162","06160","02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129092448","title":"异动解读｜药明康德盘中上涨3.09%，贝莱德增持H股提升市场情绪","url":"https://stock-news.laohu8.com/highlight/detail?id=1129092448","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1129092448?lang=zh_cn&edition=full","pubTime":"2026-10-16 09:38","pubTimestamp":1792114731,"startTime":"0","endTime":"0","summary":"10月16日，药明康德盘中上涨3.09%，报206.2港元，成交额1.63亿港元。消息面上，贝莱德在公司H股的好仓比例于10月12日由5.40%升至6.44%，增持动向强化了资金面对公司的关注。此外，公司将于10月26日召开董事会审议前三季度业绩；近期公司亦获多家机构看好，过去90天共有30家机构给出评级，机构目标均价为197.88元。多重公开信息叠加，成为股价走强的主要解释。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"药明康德上涨，贝莱德增持提振情绪","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675588167","title":"10月15日药明康德现2笔大宗交易 机构净买入502.13万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675588167","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675588167?lang=zh_cn&edition=full","pubTime":"2026-10-15 17:40","pubTimestamp":1792057220,"startTime":"0","endTime":"0","summary":"证券之星消息，10月15日药明康德发生大宗交易，交易数据如下：近三个月该股共发生22笔大宗交易，合计成交1.87万手。该股近期无解禁股上市。截至2026年10月15日收盘，药明康德(603259)报收于154.5元，上涨0.21%，换手率1.33%，成交量33.01万手，成交额50.91亿元。该股最近90天内共有30家机构给出评级，买入评级27家，增持评级3家；过去90天内机构目标均价为197.88。本文数据来源于上海证券交易所大宗交易信息披露，仅供参考不构成投资建议。相关 ETF","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500029498.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["02359","LU0700851271.USD","LU2495084118.USD","IE00B5MMRT66.SGD","LU0106959298.USD","LU0611395673.USD","LU1251922891.USD","LU1997245094.SGD","LU0052750758.USD","LU0327786744.USD","LU1979443071.USD","LU1046422090.SGD","603259","BK1583","BK0216","LU1808992512.USD","LU0072913022.USD","LU0348766576.USD","BK1141","IE00B543WZ88.USD","LU0469268626.HKD","LU2488822045.USD","LU2125910500.SGD","LU0708995583.HKD","LU0501845795.SGD","LU1997244956.HKD","IE00BPRC5H50.USD","LU2045819591.USD","LU0572944931.SGD","LU1719994722.HKD","LU1969619763.USD","LU0320764599.SGD","LU1303224171.USD","LU1770034418.SGD","LU0456842615.SGD","LU2242644610.SGD","LU1934453819.USD","LU1997245177.USD","LU0348767384.USD","BK1576","LU2328871848.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675130099","title":"贝莱德：在药明康德H股的持股比例升至6.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675130099","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675130099?lang=zh_cn&edition=full","pubTime":"2026-10-15 17:21","pubTimestamp":1792056086,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0348767384.USD","BK1141","LU0072913022.USD","LU0348766576.USD","LU1046422090.SGD","BK1583","LU2125910500.SGD","LU2045819591.USD","LU0320764599.SGD","LU0501845795.SGD","LU2242644610.SGD","LU0052750758.USD","LU0469268626.HKD","LU0572944931.SGD","LU0327786744.USD","02359","BK1576","LU0708995583.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675300766","title":"贝莱德在药明康德的H股好仓比例上升1.04%至6.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675300766","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675300766?lang=zh_cn&edition=full","pubTime":"2026-10-15 17:19","pubTimestamp":1792055940,"startTime":"0","endTime":"0","summary":"南财智讯10月15日电，香港交易所披露信息显示，BlackRock,Inc.（贝莱德）在药明康德的H股好仓（L）比例于10月12日从5.40%上升至6.44%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610153896993011.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610153896993011.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2495084118.USD","LU1997245177.USD","BK1583","IE00B5MMRT66.SGD","IE00BPRC5H50.USD","BK1141","LU2242644610.SGD","LU0700851271.USD","LU0327786744.USD","LU1770034418.SGD","LU1251922891.USD","LU1997244956.HKD","LU2045819591.USD","LU0052750758.USD","LU1969619763.USD","LU2328871848.SGD","LU1979443071.USD","LU1046422090.SGD","LU0708995583.HKD","LU0348767384.USD","LU0469268626.HKD","02359","LU0072913022.USD","LU0611395673.USD","IE00B543WZ88.USD","LU1303224171.USD","LU1808992512.USD","LU0501845795.SGD","LU1934453819.USD","LU0320764599.SGD","LU0572944931.SGD","LU1719994722.HKD","LU1997245094.SGD","BK1576","BK0216","LU0456842615.SGD","LU2488822045.USD","603259","LU0106959298.USD","LU0348766576.USD","LU2125910500.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.wuxiapptec.com.cn","stockEarnings":[{"period":"1week","weight":-0.0818},{"period":"1month","weight":-0.1144},{"period":"3month","weight":0.1737},{"period":"6month","weight":0.5131},{"period":"1year","weight":0.7658},{"period":"ytd","weight":0.8963}],"compareEarnings":[{"period":"1week","weight":-0.0452},{"period":"1month","weight":-0.0701},{"period":"3month","weight":-0.0749},{"period":"6month","weight":-0.111},{"period":"1year","weight":-0.1107},{"period":"ytd","weight":-0.099}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"无锡药明康德新药开发股份有限公司是一家主要从事新药研发和生产服务业务的中国公司。该公司主要通过六个分部开展业务。化学业务分部主要从事提供新药研究、开发与生产服务。测试业务分部主要从事提供药品、医疗器械、体外诊断试剂服务。生物学业务分部主要从事提供药物发现及研究服务。高端治疗合同测试、研发与生产（CTDMO）业务分部主要从事为客户提供医疗产品工艺开发、生产和测试一体化服务。国内新药研发服务部分部主要从事为客户提供一体化新药研发服务。其他业务分部主要从事行政服务、销售原材料和销售废料业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.026729},{"month":2,"riseRate":0.5,"avgChangeRate":0.002973},{"month":3,"riseRate":0.375,"avgChangeRate":-0.010735},{"month":4,"riseRate":0.5,"avgChangeRate":0.006501},{"month":5,"riseRate":0.375,"avgChangeRate":-0.004537},{"month":6,"riseRate":0.75,"avgChangeRate":0.089541},{"month":7,"riseRate":0.75,"avgChangeRate":0.092416},{"month":8,"riseRate":0.625,"avgChangeRate":0.059692},{"month":9,"riseRate":0.625,"avgChangeRate":0.094161},{"month":10,"riseRate":0.375,"avgChangeRate":-0.020049},{"month":11,"riseRate":0.285714,"avgChangeRate":-0.00294},{"month":12,"riseRate":0.571429,"avgChangeRate":0.03824}],"exchange":"SEHK","name":"药明康德","nameEN":"WUXI APPTEC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明康德(02359)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明康德(02359)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明康德,02359,药明康德股票,药明康德股票老虎,药明康德股票老虎国际,药明康德行情,药明康德股票行情,药明康德股价,药明康德股市,药明康德股票价格,药明康德股票交易,药明康德股票购买,药明康德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明康德(02359)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明康德(02359)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}